There are 3161 resources available
773P - Role of tumor primary chemosensitivity assessed by modeled CA-125 KELIM to predict complete interval debulking surgery (IDS) in ovarian carcinoma patients treated with neo-adjuvant chemotherapy and immunotherapy: A GINEGEPS/GINECO study of the NeoPembrOv and INeOV trials
Presenter: Pauline Corbaux
Session: Poster session 02
774P - Initial management and long-term outcome of ovarian clear cell carcinoma (OCCC) in the French multicentre ESME database
Presenter: Morgan Zenatri
Session: Poster session 02
775P - Association between chemotherapy response score (CRS) and tumour homologous recombination deficiency (tHRD) in women with newly diagnosed FIGO stage IIIC/IV high-grade serous ovarian cancer (HGSOC)
Presenter: Fiona Britton
Session: Poster session 02
776P - Liquid biopsy for the determination of homologous recombination deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study
Presenter: Alexandre Harlé
Session: Poster session 02
777P - A phase II study of the efficacy of olaparib maintenance monotherapy for patients with HRD-positive, newly diagnosed, advanced, high-grade ovarian cancer, evaluated by whole-exome sequencing (MSBM-OL)
Presenter: Katsutoshi Oda
Session: Poster session 02
778P - Efficacy and safety of pamiparib monotherapy in recurrent ovarian cancer (rOC) after prior PARPi exposure: A prospective, open label, single-arm, phase II study
Presenter: Jianqing Zhu
Session: Poster session 02
779P - Testing unselected women with newly diagnosed high-grade serous ovarian cancer (HGSOC) for germline pathogenic variants (PVs) in mismatch repair (MMR) genes is unnecessary
Presenter: Laura Spurgeon
Session: Poster session 02
780P - Propensity-score matching analysis for efficacy of platinum-based versus non-platinum chemotherapy in patients with “platinum-resistant” ovarian cancer (PROC): Real-world recent cohort study
Presenter: Alexey Rumyantsev
Session: Poster session 02
781P - Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer (PSROC) and a BRCA mutation (C-PATROL): Overall survival (OS) in predefined subgroups
Presenter: Frederik Marmé
Session: Poster session 02
782P - Predicting survival in malignant struma ovarii (MSO): A machine learning approach
Presenter: Sakhr Alshwayyat
Session: Poster session 02
Resources:
Abstract